Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
about
Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cellsComparative analysis of viral RNA signatures on different RIG-I-like receptorsDDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replicationHaploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobinBARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinaseUbiquitination of human leukocyte antigen (HLA)-DM by different membrane-associated RING-CH (MARCH) protein family E3 ligases targets different endocytic pathwaysLEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cellsFriend of Prmt1, a novel chromatin target of protein arginine methyltransferasesIdentification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoproteinThe DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replicationZinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradationHIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationCyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cellsA functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-YLEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexesIFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIVIdentification of an envelope protein from the FRD family of human endogenous retroviruses (HERV-FRD) conferring infectivity and functional conservation among simiansLentiviral vectors in gene therapy: their current status and future potentialCHD7 cooperates with PBAF to control multipotent neural crest formationEnhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapyT cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiaRepression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNAThe Nef protein of HIV-1 associates with rafts and primes T cells for activationCharacterizing the cancer genome in lung adenocarcinoma.HIV-1 nuclear import: matrix protein is back on center stage, this time together with VprAll three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restrictionRepression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivoHuman Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubulesNuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesisSIRT1 regulates HIV transcription via Tat deacetylationShort-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectorsIdentification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usageInhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.Recent Advances in Lentiviral Vaccines for HIV-1 InfectionBreaching the nuclear envelope in development and diseaseParkinson's disease: gene therapiesHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsHematopoietic-stem-cell-based gene therapy for HIV diseaseWIP regulates persistence of cell migration and ruffle formation in both mesenchymal and amoeboid modes of motility
P2860
Q21245735-C7B481DD-DBE9-4073-86AD-AB82C47358A8Q24273258-F72AC7C3-025E-4912-A59B-BE8A12AE269DQ24293603-889A6A87-A6EC-4EE3-9E4E-8FE702F6ED41Q24293797-6DE89D55-0677-4B2E-BDA2-A47C1DA92D6FQ24298631-1A8BC79E-3ED0-42A3-85A6-AD4EC276C4BAQ24302078-EF1C32DB-0160-411A-BF5E-A3920688233FQ24304259-FF4FA03D-377A-4789-AFE5-8946FE8A72D8Q24310821-6B3A59EB-85F5-408A-A28F-2838BF1401ECQ24316304-99126BCF-3549-4FF6-871C-5B24D0381176Q24318659-16B90EDC-DFCF-44DE-9E0E-F1C741C033E4Q24336663-B035C135-C362-4C1B-819B-E5CD82670AF5Q24338895-AFE48AFE-88BF-4BED-A5AF-BA4A0E6BABBBQ24536359-C5FC1D19-F46C-46A2-AEAF-72773BA08CE1Q24554232-3EFCBBE6-53D4-4EAF-AFE0-34BA3623F92EQ24562936-CECC889D-7F16-41BD-BDD5-813C992A898AQ24567990-BA8FA6FC-E668-4B58-A696-64E0520F5113Q24610558-FAFA993C-4D32-4889-83F9-C74D811CF285Q24629462-D15ED07C-A420-45BE-B1AA-EB53321CC8EAQ24630725-C329093B-A695-482C-ACCF-126DE67F49A4Q24631244-9BFFCA47-DD21-456F-8737-692F2EFAE32FQ24632975-2B8F1DC6-605B-40D7-84D3-30A839A03751Q24641909-313C8327-95F7-4820-A197-96EDB3F7BB02Q24645110-EC2D6F0C-0E5B-4F37-A10F-C43E3F74BC4DQ24649926-3CC506C8-A8CB-4ACA-B9FC-F4DD6C8EEC92Q24654217-4CDA8D4F-2275-4097-949A-930F2DE63E37Q24673961-55FEF2F2-A580-4463-9228-995763952F16Q24674585-3C563145-85DA-49C5-83DA-0D9372A45EF7Q24676221-BA11CCE1-0AC9-4436-AC3F-FB1292714984Q24681578-39564ECD-2B29-4D43-B2C2-CE8314A746C1Q24683173-A31BA598-5627-4CC1-84B7-BEF13C279FD0Q24797263-EFCCDE26-87BA-4B91-A6FF-E4F05DA6FD0BQ24802565-FFCEDBFE-5540-4A93-8934-3697EA187475Q24810805-E1F33ED1-0A25-4DDF-BB0C-1710F0B93025Q24815731-3AA5A194-3303-4BFB-B1EE-CEF5A2828CC3Q26742169-BA904712-641A-4824-BC10-0BFD367DCEE3Q26823239-6B1FDB25-5A0D-43FA-9447-A21B2CF74379Q26824184-0943809C-4F88-47EF-A63B-8C9AC0638BA8Q26859147-6AAEBB26-E8E5-4A76-B1E9-AFB66985E568Q27023434-6A0EE2D9-CF21-44DA-9CBC-11B6856D8AC2Q27310306-37187B00-96BD-479E-A918-AF5CB56AE80C
P2860
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@ast
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@en
type
label
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@ast
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@en
prefLabel
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@ast
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@en
P2093
P3181
P356
P1433
P1476
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
@en
P2093
P2888
P3181
P356
10.1038/NBT0997-871
P407
P577
1997-09-01T00:00:00Z
P6179
1006020704